Literature DB >> 29316154

Lipid profile and cytokines in hypertension of pregnancy: A comparison of preeclampsia therapies.

Yong Wang1, Dandan Shi1, Ling Chen2.   

Abstract

Hypertensive disorders complicating pregnancy can be classified as gestational hypertension, mild preeclampsia, and severe preeclampsia. It is necessary to evaluate and predict the grade in advance. The first study comprised 40 healthy pregnancies, 40 gestational hypertension, 40 mild preeclampsia, and 40 severe preeclampsia cases. The participants' lipid profile and cytokine levels were statistically compared. The efficacy and safety of oral nifedipine (n = 71) and intravenous labetalol (n = 72) for the treatment of severe preeclampsia were evaluated in the next study according to maternal and neonatal outcomes. The levels of lipid profile and cytokines were linked with the presence and severity of hypertensive disorders complicating pregnancy. Both oral nifedipine and intravenous labetalol are effective for safely reducing blood pressure to target levels in patients with severe preeclampsia. Our study suggests that lipid profile and cytokines can be used in the evaluation of the severity of hypertensive disorders complicating pregnancy, and oral nifedipine requires more study. ©2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  cytokines; labetalol; lipid profile; nifedipine; preeclampsia

Mesh:

Substances:

Year:  2018        PMID: 29316154      PMCID: PMC8031138          DOI: 10.1111/jch.13161

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  25 in total

1.  The ratio of serum paraoxonase/arylesterase activity using an improved assay for arylesterase activity to discriminate PON1(R192) from PON1(Q192).

Authors:  Mamoru Nakanishi; Yoshikazu Takanami; Taro Maruyama; Mitsuru Murata; Yoshiko Motohashi; Satomi Nakano; Kagehiro Uchida; Chizuko Maruyama; Shingo Kyotani; Motoo Tsushima
Journal:  J Atheroscler Thromb       Date:  2003       Impact factor: 4.928

2.  [Management of pre-eclampsia].

Authors:  Pierre-Emmanuel Bouet; Philippe Gillard; Philippe Descamps; Loïc Sentilhes
Journal:  Rev Prat       Date:  2014-10

Review 3.  A leading role for the immune system in the pathophysiology of preeclampsia.

Authors:  Estibalitz Laresgoiti-Servitje
Journal:  J Leukoc Biol       Date:  2013-04-30       Impact factor: 4.962

4.  Plasma triglyceride levels increase the risk for recurrent vascular events independent of LDL-cholesterol or nonHDL-cholesterol.

Authors:  Anton P van de Woestijne; Annemarie M J Wassink; Houshang Monajemi; An-Ho Liem; Hendrik M Nathoe; Yolanda van der Graaf; Frank L J Visseren
Journal:  Int J Cardiol       Date:  2012-01-21       Impact factor: 4.164

5.  Evaluation of Lp-PLA2 mass, vitronectin and PAI-1 activity levels in patients with preeclampsia.

Authors:  Özlem Balcı Ekmekçi; Hakan Ekmekçi; Zeynep Güngör; Abdullah Tüten; M Sait Toprak; Meltem Korkmaz; Mahmut Öncül; Oktay Çalışkan; Mine Kucur; Orkide Donma; Rıza Madazlı; Hüseyin Sönmez
Journal:  Arch Gynecol Obstet       Date:  2014-12-20       Impact factor: 2.344

Review 6.  Potential cell signalling mechanisms involved in differential placental angiogenesis in mild and severe pre-eclampsia.

Authors:  Carlos Escudero; Carlos Puebla; Francisco Westermeier; Luis Sobrevia
Journal:  Curr Vasc Pharmacol       Date:  2009-10       Impact factor: 2.719

7.  Lipid profile and cytokines in hypertension of pregnancy: A comparison of preeclampsia therapies.

Authors:  Yong Wang; Dandan Shi; Ling Chen
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-06       Impact factor: 3.738

Review 8.  Is inflammation the cause of pre-eclampsia?

Authors:  Wenda Ramma; Asif Ahmed
Journal:  Biochem Soc Trans       Date:  2011-12       Impact factor: 5.407

Review 9.  Shared biomarkers between female diastolic heart failure and pre-eclampsia: a systematic review and meta-analysis.

Authors:  Lisa J Alma; Anouk Bokslag; Angela H E M Maas; Arie Franx; Walter J Paulus; Christianne J M de Groot
Journal:  ESC Heart Fail       Date:  2017-01-30

10.  Serum Cholesterol and Ceruloplasmin Levels in Second Trimester can Predict Development of Pre-eclampsia.

Authors:  Madhusudan Dey; Devendra Arora; Nagarja Narayan; Reema Kumar
Journal:  N Am J Med Sci       Date:  2013-01
View more
  8 in total

1.  Combined detection of anticardiolipin and anti-β2-glycoprotein 1 antibodies may predict pregnancy outcome.

Authors:  Rongjuan Yang; Jiajia Zhang; Limei Zhang; Yongli Liu; Qing Guo
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

2.  Simultaneous use of Tumor Necrosis Factor, Lipid Profile, and β-hCG As Markers of Severity of Preeclampsia.

Authors:  Reham Elazab; Mostafa Alkhiary; Mohamed Bedairi; Alaa Wageh
Journal:  J Obstet Gynaecol India       Date:  2021-09-24

3.  Lipid profile and cytokines in hypertension of pregnancy: A comparison of preeclampsia therapies.

Authors:  Yong Wang; Dandan Shi; Ling Chen
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-06       Impact factor: 3.738

4.  Genetic markers for preeclampsia in Peruvian women.

Authors:  José Pacheco-Romero; Oscar Acosta; Doris Huerta; Santiago Cabrera; Marlene Vargas; Pedro Mascaro; Moisés Huamán; José Sandoval; Rudy López; Julio Mateus; Enrique Gil; Enrique Guevara; Nitza Butrica; Diana Catari; David Bellido; Gina Custodio; Andrea Naranjo
Journal:  Colomb Med (Cali)       Date:  2021-02-26

5.  Prevalence of preeclampsia and the associated risk factors among pregnant women in Bangladesh.

Authors:  Ananya Dutta Mou; Zitu Barman; Mahmudul Hasan; Rakib Miah; Jaasia Momtahena Hafsa; Aporajita Das Trisha; Nurshad Ali
Journal:  Sci Rep       Date:  2021-10-29       Impact factor: 4.379

Review 6.  Antihypertensive Medications for Severe Hypertension in Pregnancy: A Systematic Review and Meta-Analysis.

Authors:  Adila Awaludin; Cherry Rahayu; Nur Aizati Athirah Daud; Neily Zakiyah
Journal:  Healthcare (Basel)       Date:  2022-02-09

7.  Expression of ABCA1 Transporter and LXRA/LXRB Receptors in Placenta of Women with Late Onset Preeclampsia.

Authors:  Hubert Wolski; Marcin Ożarowski; Grażyna Kurzawińska; Anna Bogacz; Marlena Wolek; Małgorzata Łuszczyńska; Krzysztof Drews; Aleksandra E Mrozikiewicz; Przemysław Ł Mikołajczak; Radosław Kujawski; Bogusław Czerny; Tomasz M Karpiński; Agnieszka Seremak-Mrozikiewicz
Journal:  J Clin Med       Date:  2022-08-17       Impact factor: 4.964

8.  Change in cholesterol level during pregnancy and risk of postpartum depressive symptoms: the Japan Environment and Children's Study (JECS).

Authors:  Norikazu Mutsuda; Kei Hamazaki; Kenta Matsumura; Akiko Tsuchida; Haruka Kasamatsu; Hidekuni Inadera
Journal:  Acta Psychiatr Scand       Date:  2022-01-23       Impact factor: 7.734

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.